Adjunctive Therapies for Management of Type 1 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America

In this issue of Endocrinology and Metabolism Clinics, guest editors Drs.

Viral N.

Shah and Courtney Ackeifi bring their considerable expertise to the topic of Adjunctive Therapies in Type 1 Diabetes.

Top experts discuss the latest developments in adjunctive therapies to improve glycemic control, reduce complications, and enhance quality of life for individuals with type 1 diabetes.

By targeting mechanisms beyond insulin deficiency—such as insulin resistance, appetite regulation, and renal protection—adjunctive therapies hold promise for delaying disease progression, reducing insulin requirements, and minimizing adverse effects associated with intensive insulin therapy.

• Contains 14 relevant, practice-oriented topics including beyond insulin: why type 1 diabetes needs more; daily GLP-1Ras in ITD: what we’ve learned and what comes next; SGLT inhibitors for renal protection in T1D; combination of GLP-1RA and SGLT in T1D: why, when, and how; the horizon head: emerging adjunctive therapies for T1D; and more.

• Provides in-depth clinical reviews on adjunctive therapies in type 1 diabetes, offering actionable insights for clinical practice.

• Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field.

  Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.